Transthyretin amyloidosis with cardiomyopathy (ATTR-CM) is a progressive, fatal disease. Vutrisiran, a subcutaneously administered RNA interference therapeutic agent, inhibits the production of hep…
Highly pathogenic avian influenza A(H5N1) viruses have caused widespread infections in dairy cows and poultry in the United States, with sporadic human cases. We describe…
Older drugs could potentially advance U.S. hepatitis C elimination efforts. The government could act like a business and use all current and historical market information…
Quick Take Video Summary from The New England Journal of Medicine — Vutrisiran in Transthyretin Amyloidosis with Cardiomyopathy
In June 2023, the protein-based respiratory syncytial virus (RSV) vaccines Abrysvo and Arexvy were recommended in the U.S. to persons aged ≥60 years;
Increases seen in acceptance for new respiratory syncytial virus vaccines
Objectives To understand (1) healthcare professionals’ (HCPs) perceptions and experiences of commercial milk formula (CMF) marketing to consumers and HCPs and (2) HCPs’ perspectives on…
Whether a conservative strategy of medical therapy alone or a strategy of medical therapy plus invasive treatment is more beneficial in older adults with non–ST-segment…
View articles in this Published Special Issue of Applied Spectroscopy Practica
With no grandmaster moving the chess pieces of U.S. health care, weighing population density and disease distribution, rural health relies on urban centers — and…
